Comerica Bank Argenx Se Transaction History

Comerica Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 22, 2023	BUY	$360.14 - $422.58 $1.34 Million - $1.57 Million	3,720 Added 375.38%	4,711 $27,000
Q4 2022 Jan 26, 2023	SELL	$342.17 - $402.31 $8,554 - $10,057	-25 Reduced 2.46%	991 $0
Q3 2022 Oct 28, 2022	BUY	$343.2 - $395.75 $48,734 - $56,196	142 Added 16.25%	1,016 $388,000
Q2 2022 Aug 02, 2022	BUY	$269.58 - $378.88 $11,322 - $15,912	42 Added 5.05%	874 $326,000
Q1 2022 Apr 27, 2022	SELL	$254.45 - $351.06 $763 - $1,053	-3 Reduced 0.36%	832 $262,000
Q4 2021 Feb 18, 2022	SELL	$272.01 - $353.03 $16,320 - $21,181	-60 Reduced 6.7%	835 $292,000
Q3 2021 Nov 22, 2021	SELL	$295.0 - $350.58 $589,705 - $700,809	-1,999 Reduced 69.07%	895 $270,000
Q2 2021 Aug 26, 2021	BUY	$257.11 - $319.92 $4,627 - $5,758	18 Added 0.63%	2,894 $871,000
Q1 2021 Apr 28, 2021	BUY	$268.3 - $380.31 $88,270 - $125,121	329 Added 12.92%	2,876 $792,000
Q4 2020 Jan 28, 2021	BUY	$248.13 - $308.36 $32,505 - $40,395	131 Added 5.42%	2,547 $749,000
Q3 2020 Oct 30, 2020	BUY	$215.51 - $272.51 $43,102 - $54,502	200 Added 9.03%	2,416 $634,000
Q2 2020 Jul 31, 2020	BUY	$127.44 - $232.72 $13,890 - $25,366	109 Added 5.17%	2,216 $499,000
Q1 2020 May 01, 2020	BUY	$108.83 - $165.23 $229,304 - $348,139	2,107 New	2,107 $277,000

403

30.8M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $36.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.